Similar observations were made by the same group in another in vitro study in which cancer cells and lymphocytes were isolated from patients with end-stage Sézary syndrome, an interesting scenario for TNFR2 blockade, because, as already mentioned, a portion of these malignant cells show Treg features (Torrey et al., 2018). Here, TNFRSF1B is linked to cancer.